|
|
cation transport
|
GO:0006812 |
382 |
0.324
|
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
349 |
0.291
|
|
|
|
regulation of cellular component organization
|
GO:0051128 |
368 |
0.218
|
|
|
|
regulation of molecular function
|
GO:0065009 |
398 |
0.200
|
|
|
|
protein phosphorylation
|
GO:0006468 |
345 |
0.193
|
|
|
|
positive regulation of molecular function
|
GO:0044093 |
230 |
0.192
|
|
|
|
positive regulation of saliva secretion
|
GO:0046878 |
3 |
0.191
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
242 |
0.189
|
|
|
|
metal ion transport
|
GO:0030001 |
289 |
0.178
|
|
|
|
intracellular signal transduction
|
GO:0035556 |
314 |
0.140
|
|
|
|
protein complex subunit organization
|
GO:0071822 |
302 |
0.140
|
|
|
|
regulation of cell proliferation
|
GO:0042127 |
359 |
0.138
|
|
|
|
regulation of catalytic activity
|
GO:0050790 |
304 |
0.136
|
|
|
|
response to estrogen
|
GO:0043627 |
232 |
0.133
|
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
349 |
0.129
|
|
|
|
regulation of phosphorylation
|
GO:0042325 |
248 |
0.127
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
202 |
0.126
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
117 |
0.124
|
|
|
|
saliva secretion
|
GO:0046541 |
3 |
0.123
|
|
|
|
regulation of saliva secretion
|
GO:0046877 |
3 |
0.122
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
229 |
0.118
|
|
|
|
response to histamine
|
GO:0034776 |
3 |
0.113
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
165 |
0.113
|
|
|
|
apoptotic process
|
GO:0006915 |
381 |
0.113
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
283 |
0.113
|
|
|
|
reproductive process
|
GO:0022414 |
372 |
0.112
|
|
|
|
positive regulation of catalytic activity
|
GO:0043085 |
184 |
0.111
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
105 |
0.111
|
|
|
|
single organism reproductive process
|
GO:0044702 |
297 |
0.111
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
85 |
0.109
|
|
|
|
positive regulation of long term synaptic potentiation
|
GO:1900273 |
4 |
0.107
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
365 |
0.106
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
186 |
0.105
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
247 |
0.105
|
|
|
|
positive regulation of signaling
|
GO:0023056 |
270 |
0.104
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
386 |
0.104
|
|
|
|
positive regulation of phosphate metabolic process
|
GO:0045937 |
262 |
0.101
|
|
|
|
synaptic transmission
|
GO:0007268 |
235 |
0.100
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
249 |
0.100
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
77 |
0.100
|
|
|
|
response to ketone
|
GO:1901654 |
182 |
0.096
|
|
|
|
renal system process
|
GO:0003014 |
40 |
0.095
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
210 |
0.094
|
|
|
|
mapk cascade
|
GO:0000165 |
140 |
0.093
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
316 |
0.093
|
|
|
|
homeostatic process
|
GO:0042592 |
331 |
0.093
|
|
|
|
peptide secretion
|
GO:0002790 |
86 |
0.092
|
|
|
|
urinary bladder smooth muscle contraction
|
GO:0014832 |
4 |
0.090
|
|
|
|
regulation of cellular localization
|
GO:0060341 |
263 |
0.089
|
|
|
|
regulation of behavior
|
GO:0050795 |
61 |
0.088
|
|
|
|
ossification
|
GO:0001503 |
70 |
0.086
|
|
|
|
regulation of protein modification process
|
GO:0031399 |
194 |
0.086
|
|
|
|
secretion
|
GO:0046903 |
307 |
0.086
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
380 |
0.083
|
|
|
|
amine metabolic process
|
GO:0009308 |
38 |
0.082
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
203 |
0.080
|
|
|
|
regulation of cellular protein metabolic process
|
GO:0032268 |
267 |
0.080
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
191 |
0.079
|
|
|
|
neuropeptide signaling pathway
|
GO:0007218 |
29 |
0.078
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
160 |
0.078
|
|
|
|
positive regulation of intracellular signal transduction
|
GO:1902533 |
138 |
0.077
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
123 |
0.077
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
279 |
0.077
|
|
|
|
neurological system process
|
GO:0050877 |
219 |
0.076
|
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
346 |
0.076
|
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
285 |
0.076
|
|
|
|
smooth muscle contraction involved in micturition
|
GO:0060083 |
1 |
0.075
|
|
|
|
feeding behavior
|
GO:0007631 |
53 |
0.073
|
|
|
|
calcium ion transport
|
GO:0006816 |
131 |
0.073
|
|
|
|
response to estradiol
|
GO:0032355 |
164 |
0.072
|
|
|
|
cellular component biogenesis
|
GO:0044085 |
368 |
0.072
|
|
|
|
regulation of synaptic transmission glutamatergic
|
GO:0051966 |
26 |
0.071
|
|
|
|
positive regulation of cellular protein metabolic process
|
GO:0032270 |
167 |
0.070
|
|
|
|
cell cell signaling
|
GO:0007267 |
335 |
0.069
|
|
|
|
drinking behavior
|
GO:0042756 |
11 |
0.069
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
172 |
0.069
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
144 |
0.069
|
|
|
|
cellular component assembly
|
GO:0022607 |
360 |
0.068
|
|
|
|
cell migration
|
GO:0016477 |
197 |
0.067
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
132 |
0.067
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
8 |
0.067
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
49 |
0.066
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
51 |
0.066
|
|
|
|
positive regulation of cell communication
|
GO:0010647 |
271 |
0.065
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
115 |
0.064
|
|
|
|
regulation of cyclase activity
|
GO:0031279 |
21 |
0.063
|
|
|
|
chemical homeostasis
|
GO:0048878 |
292 |
0.063
|
|
|
|
organophosphate metabolic process
|
GO:0019637 |
370 |
0.063
|
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
289 |
0.062
|
|
|
|
programmed cell death
|
GO:0012501 |
392 |
0.062
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
81 |
0.061
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
231 |
0.060
|
|
|
|
blood circulation
|
GO:0008015 |
183 |
0.059
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
73 |
0.059
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
140 |
0.058
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
143 |
0.058
|
|
|
|
response to other organism
|
GO:0051707 |
220 |
0.058
|
|
|
|
reproduction
|
GO:0000003 |
245 |
0.058
|
|
|
|
urinary tract smooth muscle contraction
|
GO:0014848 |
4 |
0.058
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
36 |
0.057
|
|
|
|
cation homeostasis
|
GO:0055080 |
195 |
0.057
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
208 |
0.057
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
134 |
0.057
|
|
|
|
multi organism reproductive process
|
GO:0044703 |
262 |
0.057
|
|
|
|
ovulation cycle
|
GO:0042698 |
67 |
0.056
|
|
|
|
regulation of lyase activity
|
GO:0051339 |
22 |
0.056
|
|
|
|
positive regulation of phosphorus metabolic process
|
GO:0010562 |
262 |
0.056
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
180 |
0.055
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
45 |
0.054
|
|
|
|
hormone transport
|
GO:0009914 |
121 |
0.054
|
|
|
|
head development
|
GO:0060322 |
247 |
0.054
|
|
|
|
positive regulation of protein metabolic process
|
GO:0051247 |
178 |
0.054
|
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
60 |
0.054
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
38 |
0.054
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
118 |
0.053
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
162 |
0.053
|
|
|
|
brain development
|
GO:0007420 |
247 |
0.053
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
91 |
0.053
|
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
376 |
0.050
|
|
|
|
negative regulation of transport
|
GO:0051051 |
136 |
0.050
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
226 |
0.049
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
194 |
0.049
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
135 |
0.048
|
|
|
|
positive regulation of blood pressure by epinephrine norepinephrine
|
GO:0003321 |
2 |
0.048
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
187 |
0.048
|
|
|
|
somatostatin receptor signaling pathway
|
GO:0038169 |
4 |
0.047
|
|
|
|
cellular homeostasis
|
GO:0019725 |
252 |
0.047
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
184 |
0.047
|
|
|
|
brain renin angiotensin system
|
GO:0002035 |
3 |
0.047
|
|
|
|
angiotensin mediated drinking behavior
|
GO:0003051 |
2 |
0.046
|
|
|
|
organic acid transport
|
GO:0015849 |
116 |
0.045
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
229 |
0.045
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.045
|
|
|
|
regulation of neurological system process
|
GO:0031644 |
43 |
0.044
|
|
|
|
regulation of programmed cell death
|
GO:0043067 |
341 |
0.044
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
202 |
0.044
|
|
|
|
action potential
|
GO:0001508 |
54 |
0.044
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
167 |
0.043
|
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
77 |
0.043
|
|
|
|
positive regulation of the force of heart contraction by norepinephrine
|
GO:0003061 |
1 |
0.042
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
197 |
0.042
|
|
|
|
synaptic transmission gabaergic
|
GO:0051932 |
22 |
0.042
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
377 |
0.042
|
|
|
|
protein heterooligomerization
|
GO:0051291 |
89 |
0.041
|
|
|
|
rhythmic process
|
GO:0048511 |
156 |
0.041
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
247 |
0.041
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
142 |
0.041
|
|
|
|
endocrine process
|
GO:0050886 |
32 |
0.041
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
177 |
0.041
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
110 |
0.041
|
|
|
|
cellular response to histamine
|
GO:0071420 |
3 |
0.040
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
83 |
0.040
|
|
|
|
regulation of synaptic transmission
|
GO:0050804 |
141 |
0.040
|
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
218 |
0.039
|
|
|
|
single organism biosynthetic process
|
GO:0044711 |
342 |
0.039
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
102 |
0.039
|
|
|
|
activation of protein kinase activity
|
GO:0032147 |
47 |
0.039
|
|
|
|
signal release
|
GO:0023061 |
145 |
0.039
|
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
334 |
0.038
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
253 |
0.038
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
54 |
0.038
|
|
|
|
response to ammonium ion
|
GO:0060359 |
71 |
0.038
|
|
|
|
organic acid metabolic process
|
GO:0006082 |
292 |
0.038
|
|
|
|
camp metabolic process
|
GO:0046058 |
63 |
0.037
|
|
|
|
ion homeostasis
|
GO:0050801 |
212 |
0.037
|
|
|
|
regulation of apoptotic process
|
GO:0042981 |
335 |
0.037
|
|
|
|
cellular response to alkaloid
|
GO:0071312 |
25 |
0.037
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
49 |
0.037
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
14 |
0.037
|
|
|
|
vasoconstriction
|
GO:0042310 |
54 |
0.036
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
2 |
0.036
|
|
|
|
synaptic transmission glutamatergic
|
GO:0035249 |
33 |
0.035
|
|
|
|
negative regulation of hormone secretion
|
GO:0046888 |
46 |
0.035
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
93 |
0.035
|
|
|
|
regulation of signal transduction
|
GO:0009966 |
318 |
0.035
|
|
|
|
neurological system process involved in regulation of systemic arterial blood pressure
|
GO:0001976 |
3 |
0.035
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
80 |
0.035
|
|
|
|
response to oxygen levels
|
GO:0070482 |
265 |
0.035
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
175 |
0.035
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
25 |
0.034
|
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
281 |
0.034
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
227 |
0.034
|
|
|
|
negative regulation of metabolic process
|
GO:0009892 |
331 |
0.034
|
|
|
|
organ morphogenesis
|
GO:0009887 |
75 |
0.034
|
|
|
|
amide transport
|
GO:0042886 |
105 |
0.034
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
89 |
0.034
|
|
|
|
actin filament based process
|
GO:0030029 |
86 |
0.034
|
|
|
|
cytoskeleton organization
|
GO:0007010 |
111 |
0.034
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
32 |
0.033
|
|
|
|
biological adhesion
|
GO:0022610 |
110 |
0.033
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
47 |
0.033
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
263 |
0.033
|
|
|
|
response to growth factor
|
GO:0070848 |
189 |
0.032
|
|
|
|
adenylate cyclase inhibiting serotonin receptor signaling pathway
|
GO:0007198 |
1 |
0.032
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
29 |
0.032
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
27 |
0.032
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
62 |
0.032
|
|
|
|
regulation of locomotion
|
GO:0040012 |
148 |
0.032
|
|
|
|
cellular response to alcohol
|
GO:0097306 |
87 |
0.031
|
|
|
|
regulation of ion transport
|
GO:0043269 |
245 |
0.031
|
|
|
|
regulation of protein phosphorylation
|
GO:0001932 |
183 |
0.031
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
8 |
0.031
|
|
|
|
response to inorganic substance
|
GO:0010035 |
377 |
0.031
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
91 |
0.031
|
|
|
|
sensory perception of pain
|
GO:0019233 |
73 |
0.031
|
|
|
|
peptide transport
|
GO:0015833 |
97 |
0.031
|
|
|
|
peristalsis
|
GO:0030432 |
2 |
0.031
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
162 |
0.031
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
85 |
0.031
|
|
|
|
regulation of camp metabolic process
|
GO:0030814 |
43 |
0.031
|
|
|
|
secretion by cell
|
GO:0032940 |
248 |
0.031
|
|
|
|
response to carbohydrate
|
GO:0009743 |
183 |
0.031
|
|
|
|
estrous cycle phase
|
GO:0060206 |
15 |
0.030
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
80 |
0.030
|
|
|
|
regulation of secretion
|
GO:0051046 |
224 |
0.029
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
48 |
0.029
|
|
|
|
positive regulation of renin secretion into blood stream
|
GO:1900135 |
1 |
0.029
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
134 |
0.029
|
|
|
|
positive regulation of fat cell proliferation
|
GO:0070346 |
1 |
0.029
|
|
|
|
response to oxidative stress
|
GO:0006979 |
186 |
0.029
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
141 |
0.029
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
102 |
0.029
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
81 |
0.029
|
|
|
|
micturition
|
GO:0060073 |
4 |
0.029
|
|
|
|
positive regulation of the force of heart contraction by epinephrine norepinephrine
|
GO:0001997 |
2 |
0.029
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
235 |
0.028
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
124 |
0.028
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
136 |
0.028
|
|
|
|
artery smooth muscle contraction
|
GO:0014824 |
4 |
0.028
|
|
|
|
response to peptide hormone
|
GO:0043434 |
278 |
0.028
|
|
|
|
protein complex assembly
|
GO:0006461 |
263 |
0.027
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
96 |
0.027
|
|
|
|
smooth muscle contraction
|
GO:0006939 |
37 |
0.027
|
|
|
|
forebrain development
|
GO:0030900 |
98 |
0.027
|
|
|
|
phospholipase c activating serotonin receptor signaling pathway
|
GO:0007208 |
2 |
0.027
|
|
|
|
response to hypoxia
|
GO:0001666 |
231 |
0.027
|
|
|
|
central nervous system development
|
GO:0007417 |
311 |
0.027
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
172 |
0.027
|
|
|
|
anion transport
|
GO:0006820 |
178 |
0.027
|
|
|
|
positive regulation of multicellular organismal process
|
GO:0051240 |
387 |
0.027
|
|
|
|
macromolecular complex subunit organization
|
GO:0043933 |
339 |
0.026
|
|
|
|
renal response to blood flow involved in circulatory renin angiotensin regulation of systemic arterial blood pressure
|
GO:0001999 |
1 |
0.026
|
|
|
|
vasodilation by norepinephrine epinephrine involved in regulation of systemic arterial blood pressure
|
GO:0002025 |
1 |
0.026
|
|
|
|
negative regulation of ion transport
|
GO:0043271 |
51 |
0.026
|
|
|
|
positive regulation of synaptic vesicle exocytosis
|
GO:2000302 |
3 |
0.026
|
|
|
|
regulation of system process
|
GO:0044057 |
208 |
0.026
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
87 |
0.026
|
|
|
|
cerebral cortex tangential migration
|
GO:0021800 |
1 |
0.026
|
|
|
|
n methyl d aspartate receptor clustering
|
GO:0097114 |
2 |
0.026
|
|
|
|
muscle contraction
|
GO:0006936 |
88 |
0.026
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
68 |
0.026
|
|
|
|
synaptic transmission glycinergic
|
GO:0060012 |
2 |
0.026
|
|
|
|
cyclic nucleotide biosynthetic process
|
GO:0009190 |
63 |
0.026
|
|
|
|
cellular response to stress
|
GO:0033554 |
269 |
0.026
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
72 |
0.025
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
128 |
0.025
|
|
|
|
axon choice point recognition
|
GO:0016198 |
2 |
0.025
|
|
|
|
positive regulation of transport
|
GO:0051050 |
245 |
0.025
|
|
|
|
lipid metabolic process
|
GO:0006629 |
283 |
0.024
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
117 |
0.024
|
|
|
|
protein complex biogenesis
|
GO:0070271 |
263 |
0.024
|
|
|
|
negative regulation of cyclic nucleotide metabolic process
|
GO:0030800 |
15 |
0.024
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
90 |
0.024
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
85 |
0.024
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
106 |
0.024
|
|
|
|
negative regulation of cell communication
|
GO:0010648 |
158 |
0.024
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
147 |
0.024
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
65 |
0.024
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
122 |
0.024
|
|
|
|
multicellular organismal reproductive process
|
GO:0048609 |
233 |
0.024
|
|
|
|
tonic smooth muscle contraction
|
GO:0014820 |
4 |
0.024
|
|
|
|
adenylate cyclase inhibiting g protein coupled receptor signaling pathway
|
GO:0007193 |
19 |
0.024
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
221 |
0.024
|
|
|
|
response to corticosteroid
|
GO:0031960 |
235 |
0.023
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
1 |
0.023
|
|
|
|
defense response
|
GO:0006952 |
194 |
0.023
|
|
|
|
organic anion transport
|
GO:0015711 |
132 |
0.023
|
|
|
|
neurotransmitter gated ion channel clustering
|
GO:0072578 |
3 |
0.023
|
|
|
|
response to wounding
|
GO:0009611 |
254 |
0.023
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
229 |
0.023
|
|
|
|
neuron development
|
GO:0048666 |
286 |
0.023
|
|
|
|
positive regulation of brown fat cell proliferation
|
GO:0070349 |
1 |
0.023
|
|
|
|
positive regulation of the force of heart contraction by epinephrine
|
GO:0003059 |
1 |
0.023
|
|
|
|
response to progesterone
|
GO:0032570 |
48 |
0.023
|
|
|
|
protein oligomerization
|
GO:0051259 |
191 |
0.023
|
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
319 |
0.023
|
|
|
|
response to interleukin 1
|
GO:0070555 |
55 |
0.023
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
264 |
0.022
|
|
|
|
regulation of endocrine process
|
GO:0044060 |
21 |
0.022
|
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
50 |
0.022
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
163 |
0.022
|
|
|
|
nucleobase containing compound catabolic process
|
GO:0034655 |
152 |
0.022
|
|
|
|
sodium ion transport
|
GO:0006814 |
82 |
0.022
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
42 |
0.022
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
92 |
0.022
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
51 |
0.022
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
139 |
0.021
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
179 |
0.021
|
|
|
|
positive regulation of response to external stimulus
|
GO:0032103 |
51 |
0.021
|
|
|
|
positive regulation of somatostatin secretion
|
GO:0090274 |
4 |
0.021
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
143 |
0.021
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
50 |
0.021
|
|
|
|
positive regulation of the force of heart contraction by chemical signal
|
GO:0003099 |
2 |
0.021
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
124 |
0.021
|
|
|
|
regulation of sodium ion transmembrane transporter activity
|
GO:2000649 |
4 |
0.021
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
48 |
0.020
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
181 |
0.020
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
110 |
0.020
|
|
|
|
phasic smooth muscle contraction
|
GO:0014821 |
3 |
0.020
|
|
|
|
cardiovascular system development
|
GO:0072358 |
134 |
0.020
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
122 |
0.020
|
|
|
|
regulation of cell development
|
GO:0060284 |
263 |
0.020
|
|
|
|
response to toxic substance
|
GO:0009636 |
133 |
0.020
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
4 |
0.020
|
|
|
|
wound healing
|
GO:0042060 |
122 |
0.020
|
|
|
|
cellular component movement
|
GO:0006928 |
248 |
0.020
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
84 |
0.020
|
|
|
|
response to radiation
|
GO:0009314 |
137 |
0.020
|
|
|
|
regulation of smooth muscle contraction
|
GO:0006940 |
29 |
0.020
|
|
|
|
response to mineralocorticoid
|
GO:0051385 |
49 |
0.020
|
|
|
|
carboxylic acid metabolic process
|
GO:0019752 |
289 |
0.019
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
179 |
0.019
|
|
|
|
vasculature development
|
GO:0001944 |
70 |
0.019
|
|
|
|
regulation of tube size
|
GO:0035150 |
89 |
0.019
|
|
|
|
positive regulation of heart contraction
|
GO:0045823 |
15 |
0.019
|
|
|
|
renin secretion into blood stream
|
GO:0002001 |
1 |
0.019
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
320 |
0.019
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
140 |
0.019
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
162 |
0.019
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
98 |
0.019
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
107 |
0.019
|
|
|
|
regulation of camp biosynthetic process
|
GO:0030817 |
38 |
0.019
|
|
|
|
regulation of alpha amino 3 hydroxy 5 methyl 4 isoxazole propionate selective glutamate receptor activity
|
GO:2000311 |
11 |
0.019
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
53 |
0.019
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
53 |
0.019
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
48 |
0.019
|
|
|
|
positive regulation of signal transduction
|
GO:0009967 |
175 |
0.019
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
1 |
0.019
|
|
|
|
regulation of synaptic transmission cholinergic
|
GO:0032222 |
6 |
0.019
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
237 |
0.018
|
|
|
|
fat cell proliferation
|
GO:0070341 |
2 |
0.018
|
|
|
|
response to monosaccharide
|
GO:0034284 |
159 |
0.018
|
|
|
|
sensory perception
|
GO:0007600 |
101 |
0.018
|
|
|
|
inflammatory response
|
GO:0006954 |
150 |
0.018
|
|
|
|
response to nutrient levels
|
GO:0031667 |
370 |
0.018
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
52 |
0.018
|
|
|
|
positive regulation of synaptic transmission cholinergic
|
GO:0032224 |
6 |
0.018
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
55 |
0.018
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
116 |
0.018
|
|
|
|
organelle organization
|
GO:0006996 |
266 |
0.018
|
|
|
|
hormone secretion
|
GO:0046879 |
115 |
0.018
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
72 |
0.018
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
121 |
0.018
|
|
|
|
regulation of fat cell proliferation
|
GO:0070344 |
1 |
0.017
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
46 |
0.017
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
122 |
0.017
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
150 |
0.017
|
|
|
|
adenylate cyclase inhibiting opioid receptor signaling pathway
|
GO:0031635 |
2 |
0.017
|
|
|
|
tissue development
|
GO:0009888 |
252 |
0.017
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
42 |
0.017
|
|
|
|
response to heat
|
GO:0009408 |
60 |
0.017
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
101 |
0.017
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
141 |
0.017
|
|
|
|
response to hyperoxia
|
GO:0055093 |
45 |
0.017
|
|
|
|
response to ethanol
|
GO:0045471 |
162 |
0.017
|
|
|
|
negative regulation of camp biosynthetic process
|
GO:0030818 |
12 |
0.017
|
|
|
|
response to peptide
|
GO:1901652 |
292 |
0.017
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
128 |
0.017
|
|
|
|
angiogenesis
|
GO:0001525 |
53 |
0.017
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
148 |
0.017
|
|
|
|
cell activation
|
GO:0001775 |
97 |
0.017
|
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
319 |
0.017
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
157 |
0.017
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
169 |
0.017
|
|
|
|
negative regulation of uterine smooth muscle contraction
|
GO:0070473 |
2 |
0.017
|
|
|
|
generation of ovulation cycle rhythm
|
GO:0060112 |
2 |
0.017
|
|
|
|
response to bacterium
|
GO:0009617 |
200 |
0.017
|
|
|
|
eye morphogenesis
|
GO:0048592 |
4 |
0.017
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
44 |
0.016
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
74 |
0.016
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
126 |
0.016
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
48 |
0.016
|
|
|
|
localization of cell
|
GO:0051674 |
202 |
0.016
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
12 |
0.016
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
72 |
0.016
|
|
|
|
involuntary skeletal muscle contraction
|
GO:0003011 |
2 |
0.016
|
|
|
|
multicellular organism reproduction
|
GO:0032504 |
233 |
0.016
|
|
|
|
regulation of sensory perception of pain
|
GO:0051930 |
29 |
0.016
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
49 |
0.016
|
|
|
|
single organism behavior
|
GO:0044708 |
130 |
0.016
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
106 |
0.016
|
|
|
|
uterine smooth muscle contraction
|
GO:0070471 |
10 |
0.016
|
|
|
|
macromolecule localization
|
GO:0033036 |
252 |
0.016
|
|
|
|
locomotory exploration behavior
|
GO:0035641 |
1 |
0.016
|
|
|
|
synaptic transmission cholinergic
|
GO:0007271 |
11 |
0.016
|
|
|
|
negative regulation of signaling
|
GO:0023057 |
157 |
0.015
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
115 |
0.015
|
|
|
|
response to alkaloid
|
GO:0043279 |
132 |
0.015
|
|
|
|
response to glucose
|
GO:0009749 |
136 |
0.015
|
|
|
|
response to light stimulus
|
GO:0009416 |
52 |
0.015
|
|
|
|
positive regulation of cardiac muscle tissue growth
|
GO:0055023 |
9 |
0.015
|
|
|
|
coronary vasculature morphogenesis
|
GO:0060977 |
3 |
0.015
|
|
|
|
positive regulation of synaptic transmission
|
GO:0050806 |
62 |
0.015
|
|
|
|
c21 steroid hormone biosynthetic process
|
GO:0006700 |
10 |
0.015
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
122 |
0.015
|
|
|
|
smooth muscle cell migration
|
GO:0014909 |
36 |
0.015
|
|
|
|
regulation of catabolic process
|
GO:0009894 |
113 |
0.015
|
|
|
|
cellular response to estradiol stimulus
|
GO:0071392 |
16 |
0.015
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
38 |
0.015
|
|
|
|
muscle cell migration
|
GO:0014812 |
36 |
0.015
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
200 |
0.015
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
115 |
0.015
|
|
|
|
diaphragm contraction
|
GO:0002086 |
2 |
0.015
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
11 |
0.015
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
29 |
0.015
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
97 |
0.015
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
82 |
0.015
|
|
|
|
response to acid chemical
|
GO:0001101 |
222 |
0.015
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
83 |
0.015
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
123 |
0.015
|
|
|
|
eating behavior
|
GO:0042755 |
21 |
0.014
|
|
|
|
peptide metabolic process
|
GO:0006518 |
32 |
0.014
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
106 |
0.014
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
73 |
0.014
|
|
|
|
positive regulation of cyclase activity
|
GO:0031281 |
15 |
0.014
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
26 |
0.014
|
|
|
|
reproductive structure development
|
GO:0048608 |
128 |
0.014
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
47 |
0.014
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
168 |
0.014
|
|
|
|
negative regulation of gamma aminobutyric acid secretion
|
GO:0014053 |
3 |
0.014
|
|
|
|
macromolecular complex assembly
|
GO:0065003 |
273 |
0.014
|
|
|
|
membrane hyperpolarization
|
GO:0060081 |
11 |
0.014
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
136 |
0.014
|
|
|
|
regulation of the force of heart contraction by chemical signal
|
GO:0003057 |
2 |
0.014
|
|
|
|
regulation of cell activation
|
GO:0050865 |
50 |
0.014
|
|
|
|
regulation of defense response
|
GO:0031347 |
68 |
0.014
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
26 |
0.014
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
4 |
0.014
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
125 |
0.014
|
|
|
|
proteolysis
|
GO:0006508 |
175 |
0.014
|
|
|
|
potassium ion homeostasis
|
GO:0055075 |
2 |
0.014
|
|
|
|
cellular response to ammonium ion
|
GO:0071242 |
17 |
0.014
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
58 |
0.014
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
183 |
0.014
|
|
|
|
organic substance catabolic process
|
GO:1901575 |
316 |
0.014
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
4 |
0.014
|
|
|
|
female pregnancy
|
GO:0007565 |
122 |
0.014
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
283 |
0.014
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
115 |
0.014
|
|
|
|
potassium ion transport
|
GO:0006813 |
97 |
0.014
|
|
|
|
regulation of smooth muscle cell migration
|
GO:0014910 |
36 |
0.014
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
138 |
0.014
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
1 |
0.013
|
|
|
|
negative regulation of nucleotide biosynthetic process
|
GO:0030809 |
12 |
0.013
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
126 |
0.013
|
|
|
|
positive regulation of inhibitory postsynaptic membrane potential
|
GO:0097151 |
3 |
0.013
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
30 |
0.013
|
|
|
|
positive regulation of calcium ion transport
|
GO:0051928 |
36 |
0.013
|
|
|
|
regulation of skeletal muscle tissue growth
|
GO:0048631 |
3 |
0.013
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
80 |
0.013
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
247 |
0.013
|
|
|
|
developmental induction
|
GO:0031128 |
2 |
0.013
|
|
|
|
regulation of response to stress
|
GO:0080134 |
126 |
0.013
|
|
|
|
negative regulation of glutamate secretion
|
GO:0014050 |
9 |
0.013
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
9 |
0.013
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
182 |
0.013
|
|
|
|
axon midline choice point recognition
|
GO:0016199 |
2 |
0.013
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
46 |
0.013
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
141 |
0.013
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
87 |
0.013
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
154 |
0.013
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
167 |
0.013
|
|
|
|
regulation of growth
|
GO:0040008 |
105 |
0.013
|
|
|
|
regulation of vasoconstriction
|
GO:0019229 |
44 |
0.013
|
|
|
|
muscle tissue development
|
GO:0060537 |
58 |
0.013
|
|
|
|
response to camp
|
GO:0051591 |
91 |
0.013
|
|
|
|
operant conditioning
|
GO:0035106 |
4 |
0.013
|
|
|
|
glucose homeostasis
|
GO:0042593 |
75 |
0.013
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
53 |
0.013
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
67 |
0.013
|
|
|
|
positive regulation of growth
|
GO:0045927 |
55 |
0.013
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
94 |
0.012
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
124 |
0.012
|
|
|
|
regulation of brown fat cell proliferation
|
GO:0070347 |
1 |
0.012
|
|
|
|
intracellular transport
|
GO:0046907 |
185 |
0.012
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
66 |
0.012
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
174 |
0.012
|
|
|
|
limbic system development
|
GO:0021761 |
38 |
0.012
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
126 |
0.012
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
71 |
0.012
|
|
|
|
serotonin receptor signaling pathway
|
GO:0007210 |
10 |
0.012
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
71 |
0.012
|
|
|
|
neuron differentiation
|
GO:0030182 |
368 |
0.012
|
|
